Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma
Trial ID or NCT#
NCT05079282
Status
RECRUITING
Purpose
This study will investigate the safety, tolerability, pharmacokinetics, and preliminary efficacy of ONO-4685 in patients with relapsed or refractory T cell Lymphoma
Official Title
An Open-label, Multi-center, Non-randomized Phase I Dose Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ONO-4685 Given as Monotherapy in Patients With Relapsed or Refractory T Cell Lymphoma
Investigator(s)
Michael Khodadoust
Lymphoma specialist,
Cutaneous oncology specialist,
Hematologist,
Hematologist-Oncologist
Assistant Professor of Medicine (Oncology) and of Dermatology
Contact us to find out if this trial is right for you.
Contact
Kumari Sinha Khushboo
View on ClinicalTrials.gov
